You are here: vision-research.eu » People » Researcher » Sørensen, Torben Lykke

Torben Lykke Sørensen

Short CV

Torben Lykke Sørensen serves as a Board Certified Ophthalmologist, who received his M.D. degree from the University of Copenhagen, Denmark, in 1999 and his D.M.S. degree in 2004 on a thesis describing chemokines and chemokine receptors in optic neuritis and multiple sclerosis.

Presently, he holds joint appointments as a Chief Physician, as a Clinical Associate Research Professor at the University of Copenhagen, and as the Head of the Research Unit at the Department of Ophthalmology, Copenhagen University Hospital Roskilde, Denmark.

Current research is mainly focused on the immunology and clinical aspects of age-related macular degeneration as well as other retinal and immunological eye diseases. 

Torben Lykke Soerensen
Torben Lykke Soerensen

Research Group

Eye Research Group Roskilde

[more information]

Contact

Copenhagen University Hospital Roskilde

Department of Ophthalmology

Køgevej 7-13
4000 Roskilde
Denmark

Phone: +45 47323900

E-mail:
tlso[at]regionsjaelland.dk

Website:
Clinical Eye Research Unit

Key Publications

  1. T.L. Sørensen, H. Kemp.
    Effect of Ranibizumab in patients with choroidal neovascularisation and very low vision.
    Acta Ophthalmol vol. 89, no. 1, pp. e97, 2011
  2. Singh A, Sørensen T.L.
    Symptoms of Charles Bonnet Syndrome decreases, if treatment with Ranibizumab is effective in age-related macular degeneration.
    Br J Ophthalmol vol. 95, no. 2, pp. 291–292, 2011
  3. Singh A, Sørensen T.L.:
    The prevalence and clinical characteristics of Charles Bonnet syndrome in a Danish population with age-related macular degeneration.
    Acta Ophthalmol 2010 e-pub ahead of print
  4. MS Eghøj & T.L.Sørensen.
    Development of tachyphylaxis during treatment of age-related macular degeneration with ranibizumab.
    Br J Ophthalmol. vol. 96, no. 1, pp. 21–23, 2012
  5. H Hamoudi & T.L.Sørensen.
    Effect of intravitreal ranibizumab in the treatment of peripapillary chorodial neovascularisation.
    Journal of Ophthalmology 2011 epub in press.
  6. A Singh, M Falk, C Faber, MH Nissen, THV Hviid, T.L. Sørensen.
    Altered expression of CD46 and CD59 on leukocytes in age-related macular degeneration.
    Am J Ophthalmol vol. 154, no. 1, pp. 193–199, 2012
  7. J Jørgensen, H Kemp, T.L. Sørensen.
    Identification of foreign bodies on the ocular surface after uneventful intravitreal injections.
    Acta Ophthalmol 2012 E-pub ahead of print
  8. M Falk, H Kemp, T.L. Sørensen.
    Four year treatment results of neovascular age-related macular degeneration.
    Am J Ophthalmol (in press)
  9. T.L. Sørensen, P Haamann, J Villumsen, M Larsen.
    Intravitreal triamcinolone for macula edema: efficacy in relation to etiology.
    Acta Ophthalmol Scand 2005; 83(1): 67-70.

Research Groups

People

Missing some information on vision-research.eu?

* mandatory field